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Abstract: The aim of the present work is the presentation of a quantification methodology for 
the control of the amount of superparamagnetic iron oxide nanoparticles (SPIONs) administered 
in biological materials by means of the ferromagnetic resonance technique (FMR) applied to 
studies both in vivo and in vitro. The in vivo study consisted in the analysis of the elimination 
and biodistribution kinetics of SPIONs after intravenous administration in Wistar rats. The 
results were corroborated by X-ray fluorescence. For the in vitro study, a quantitative analysis 
of the concentration of SPIONs bound to the specific AC133 monoclonal antibodies was car-
ried out in order to detect the expression of the antigenic epitopes (CD133) in stem cells from 
human umbilical cord blood. In both studies FMR has proven to be an efficient technique for 
the SPIONs quantification per volume unit (in vivo) or per labeled cell (in vitro).
Keywords: quantification, FMR, ferrofluid, biodistribution, nanoparticles
Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) are known to consist of 
ferromagnetic single domains with great potential for biological and medical 
applications.1–3 A considerable number of preliminary studies have been performed 
to address issues such as toxicity,4–6 kinetics of elimination and biodistribution of 
the nanoparticles in the different tissues,7–9 biocompatibility,9 cellular labeling,10–12 
qualitative visualization of the tissue or the labeled cell,5,13–15 viability and cellular pro-
liferation,5,6,14 differentiation assays,16,17 kinetics of the SPIONs-trapping capability,18 
analysis of the qualitative biodistribution,19 efficiency of cellular labeling,6,13,14,16 and 
qualitative analysis of the iron content,5,20–22 among others.
In biological and medical applications, an important point involved with the 
utilization of the SPIONs is the iron quantitative analysis. For example, in in vivo 
studies, it is necessary to determine: i) the quantity of iron that was absorbed or 
bound to the different tissues after SPIONs administration; ii) the iron absorption 
or elimination rate; iii) whether the amount of iron administered per volume unit is 
toxic or not to the tissue or to the cell; iv) and what is the ideal dose to obtain the 
desired effect in the particular application, among others. In applications of magnetic 
resonance imaging (MRI), these parameters will allow the contrast effect in the signal 
intensity to be determined, resulting in a better contrast control due to the presence 
of SPIONs. In in vitro studies the quantitative analysis of the SPIONs has the fol-
lowing fundamental objectives: i) determination of the relation between the signal 
intensity and the number of the labeled cells, as well as the signal intensity and the International Journal of Nanomedicine 2010:5 204
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administered SPIONs concentration (taking into account the 
study of the toxicity of the contrast agent of cellular label); 
ii) determination of the ideal dose and the ideal time after 
the SPIONs administration (result of the study of the kinetics 
and the tissue SPIONs trapping capability) to obtain a good 
contrast for MRI; iii) determining the quantity of cells that 
can be detected in vivo or in vitro by MRI; and iv) to verify 
how the MRI signal intensity is related with the cellular 
proliferation and migration.
The objective of this work is to present the quantification 
methodology of SPIONs for the studies in biological materi-
als by means of ferromagnetic resonance (FMR) both in vivo 
and in vitro. For the in vivo case, FMR was used to monitor 
the kinetics of ferrofluid elimination and biodistribution after 
the SPIONs administration, with the results corroborated 
by X-ray fluorescence (XRF) measurements. In the in vitro 
study, hematopoietic stem cells from human umbilical cord 
blood were labeled with SPIONs coupled to a specific AC133 
monoclonal antibody in order to monitor the expression of 
the antigenic CD133 label.
Experimental procedure
Methodology of quantification
The methodology here described is intended to provide a 
quantitative analysis of iron oxide nanoparticles in biological 
materials by means of FMR technique. The analysis allows 
one to have a better control of the SPIONs dose administered 
in biological materials. Such methodology can be summa-
rized as follows:
a)  Perform an initial qualitative visualization of the studied 
tissue in order to observe the SPIONs location as well as 
the conservation of the cells morphology, thus validating 
the posterior quantification analysis.
b)  In the FMR spectrum, assign the peaks that specifically 
correspond to SPIONs, since other iron species that do 
not come from the administered SPIONs can also con-
tribute peaks to the FMR spectrum. This identification 
is to be performed carefully by measurements of FMR 
spectra at different temperatures, taking into account the 
blocking temperature of the nanoparticles. For FMR mea-
surements, room temperature is recommended because 
at higher temperatures changes that lead to irreversible 
damages in the samples can happen.
c)  Build the calibration curve for the ferrofluid using dif-
ferent known concentrations which are proportional to 
the areas under the resonance absorption curves (doubly 
integrated FMR experimental spectrum) of the SPIONs. 
This curve will allow an indirect interpolation during 
the quantification process. The parameters of the FMR 
data acquisition used to construct the curve as well as the 
volume of the sample for all the concentrations must be 
equal.
d)  After confirming the presence of the SPIONs in the tissues 
(desired target), assigning the SPIONs resonance line, 
and taking into account the calibration curve, the SPIONs 
quantification is performed for the different samples as 
follows:
•  Carry out FMR measurements of the studied samples, 
where the parameters used for data acquisition (not neces-
sarily the same of the calibration curve) and the volume 
of the samples must be equal.
•  Take a FMR spectrum of a sample with known SPIONs 
concentration. Then, interpolate the value of the area 
under the absorption signal in the calibration curve in 
order to obtain a “factor” to be multiplied by the areas 
obtained from measured FMR spectra of the samples 
under study and thus to find the correspondent concentra-
tions (indirect calibration).
This paper is concerned with the application of this 
method in two cases of quantification (in vivo and in vitro), 
where we describe the details and indicate the necessary 
precautions.
case I: in vivo study
The process of SPIONs quantification in vivo was conducted 
in the study of the kinetics of elimination in the blood and 
biodistribution in the liver of the biocompatible ferrofluid 
constituted by Fe3O4 nanoparticles recovered with dextran, 
and administered via intravenous in Wistar rats. The FMR 
results were verified by the use of XRF technique.
Ferrofluid: Contrast agent
The biocompatible ferrofluid used in the in vivo study is 
an aqueous colloid of Fe3O4 SPIONs (Endorem, Guerbet, 
France) coated with low-molecular-weight dextran 
(7–9 kDa);23 the iron oxide crystal is 4.8–5.6 nm, and the 
hydrodynamic diameter is 80–150 nm. Each milliliter of 
Endorem contains: 11.2 mg of iron, 5.6–9.1 mg/mL of dex-
tran, 0.25–0.53 mg/mL of citric acid, and 61.3 mg/mL of 
β-d-manitol (C6H14O6).
Protocol for sPIONs administration
A number of 16 male Wistar rats (90 days old) with average 
body weight of 420 g was selected. After alimentary starving, 
the animals were weighed and anesthetized with ketamine 
chlorohydrate (100 mg/kg) and chlorohydrate of xilazine International Journal of Nanomedicine 2010:5 205
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(10 mg/kg), mixed in the same syringe and injected intra-
muscularly. After 20 minutes, a solution of the biocompatible 
ferrofluid, at the concentration of 15 µmol of Fe/kg of body 
weight, was slowly injected (about 10 minutes).
Samples of blood were collected during the periods of 
5, 15, 30, 45, 60, 90, and 180 min, and the animals were sub-
sequently sacrificed in a CO2 chamber. Samples of liver were 
collected after each sacrifice. The control was performed with 
rats that were not injected with the ferrofluid.
The collected samples were then lyophilized in an 
Edwards equipment, model E3M8-Modulyo, in order to 
achieve an optimum homogeneity for the subsequent analy-
ses of the kinetics of elimination and biodistribution of the 
ferrofluid using the techniques of FMR and XRF.
Quantification protocol
Visualization of the sPIONs in the studied tissue
The samples of liver were fixed in Bouin and included in 
Paraplast® (McCormick Scientific, St. Louis, MO, USA). For 
the histological analysis, incisions (5 µm thick) were colored 
with hematoxylin and eosin (HE). For the detection of ferric 
ions the cuts were submitted to the reaction with Prussian 
blue (Perls method) and countercolored with a solution of 
safranine. The analysis and the documentation of the cuts 
were performed in a light microscope (Axiophot; Carl Zeiss, 
Oberkochen, Germany).
Identification of the SPIONs in the samples by FMR
In the study of SPIONs elimination and biodistribution, it was 
necessary to determine the iron entities present in the liver 
and blood of the rats after the administration of the ferrofluid. 
The FMR spectra were acquired using lyophilized samples 
of the liver and blood. In the search for the best FMR signal, 
the spectra were obtained at different temperatures using a 
spectrometer operating at X-band. The FMR measurements 
were performed using an ELEXSYS E580 spectrometer 
(Bruker BioSpin, São Paulo, Brazil) operating at 9.4 GHz. 
The samples were placed in a quartz tube which was in turn 
positioned in the center of a rectangular microwave cavity 
operating in the TE102 mode. To perform experiments at 
different temperatures (4, 100, and 298 K) with liver and 
blood samples, the FMR spectrometer was also equipped 
with a helium gas flow cryostat (continuous flow cryostat 
CF935; Oxford Instruments, Abingdon, UK) mounted inside 
the microwave cavity. The temperature of the sample was 
controlled with an ITC503 Oxford Instruments temperature 
control unit and the spectra were collected after the samples 
reached thermal equilibrium. In order to avoid saturation and 
distortion of the FMR signal, the following experimental 
parameters were used: center field 2,500 Gauss; sweep width 
4,900 Gauss; modulation amplitude, 3.0 Gauss; modulation 
frequency, 100 kHz; microwave power 10 mW; conversion 
time, 81.92 ms; time constant, 20.48 ms.
calibration curve
The calibration curve shown in Figure 1 was constructed 
in order to determine the average number of SPIONs per 
volume unit of the samples being studied. Samples of the 
ferrofluid (Endorem) were prepared with colloidal suspen-
sions at different concentrations varying from 0.3 to 101 × 
1013 SPION/mm3. A 2 µL volume of each sample was inserted 
into capillary quartz tubes for the acquisition of the FMR 
spectra as shown in Figure 1A. Each point in the calibration 
curve was the result of three scans and the plotted value 
represents the average of these measurements.
Since the derivative of the absorption curve is measured 
in an FMR experiment, the intensity of each FMR spectrum 
is determined from the double integration of the experimental 
resonance peaks (in our case, the peak at g = 2.1 was assigned 
to the iron-containing SPIONs). The g-value was obtained from 
the relation g = (hν/(βH0)) = (2.12 ± 0.02), with ν = 9.428 GHz, 
where h is the Planck constant, ν is the microwave frequency 
and β is the Bohr magneton. The intensity of the FMR spectrum 
at g = 2.1 is proportional to the number of iron particles per mm3 
(concentration of SPIONs). The values obtained from the FMR 
intensities associated with the iron concentrations were plotted 
and the calibration curve was obtained (solid line in Figure 1). 
The uncertainty in each experimental calibration point was 
estimated to be in the range 0.3–2.0 × 1011, which thus cannot 
be seen in the same scale used in Figure 1.
In order to check the results obtained in vivo by FMR a 
study was conducted using the technique of XRF and cali-
bration curves were also built for samples of the ferrofluid 
Endorem as well as the standard samples 1577b and 1548a 
of the National Institute of Standards and Technology. The 
XRF powder calibration curve relates the characteristic 
line of iron (shown in Figure 1B) versus the concentration 
of the iron particles exhibited by the dashed line in Figure 1. 
The XRF measurements were performed using EDX-980 
equipment (Shimadzu, São Paulo, Brazil).
The fraction of iron due to administered SPIONs was 
obtained from the differences between the XFR iron line in 
the control sample and the same line in the studied sample 
thus yielding a real value of the iron content in the organs 
being studied, and due only to the administered substance. 
The same procedure was adopted in the FMR studies.International Journal of Nanomedicine 2010:5 206
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Figure 1 FMR (solid line) and XRF (dashed line) calibration curves of the sPIONs related to the area under the resonance line at g = 2.1 and the characteristic FeKa line, 
respectively. In the inset A) there are seen typical FMR spectra for different concentrations of iron, corresponding to the characteristic line of magnetite contained in the 
ferrofluid EndoremTM. Inset B) shows the characteristic FeKa line of XRF, proportional to the iron concentration in the sample.
Abbreviations: FMR, ferromagnetic resonance; SPIONs, superparamagnetic iron oxide nanoparticles; XRF, X-ray fluorescence.
FMR measurements
The FMR spectra were acquired using lyophilized samples of 
the liver and blood. For the purpose of performing the indirect 
interpolation was used a volume of 0.1 mL of the ferrofluid 
(Endorem) of known concentration (5 × 1013 particles/mm3).
case II: in vitro study
The in vitro quantification of SPIONs by means of FMR 
comprised the labeling of CD133+ stem cells from the blood 
of human umbilical cord. The SPIONs are coupled to AC133 
monoclonal antibody, which recognizes the antigenic epitope 
CD133. The CD133+ cells from human cord blood could 
represent a primary step to gain access to a stem pool useful 
for therapeutic hematopoietic transplants, stem cell expan-
sion for clinical purposes and pre-clinical research on tissue 
regenerating therapies.
Ferrofluid cellular label
CD133 cells were labeled by using the AC133 monoclonal 
antibody coupled to the SPIONs – Fe3O4 – (Miltenyi Bio-
tec, Bergisch Gladbach, Germany) with average particle 
diameter of 9 nm. These nanoparticles were dispersed in 
a colloidal suspension of a ferrofluid containig 0.1% of 
gelatine, 0.05% of sodium azide, and an iron content of 
200 µg/mL.
Protocol for labeling cD133 cells with sPIONs
Blood from umbilical cord cells were obtained from donor 
volunteers (n = 5) after written consent (CEP–IEPAE 
No.105/02). Mononuclear cells were purified by density-
gradient centrifugation using Ficoll-PaqueTM Plus (GE 
Healthcare, Chalfont St. Giles, UK).24
After the separation of the mononuclear cells, the 
CD133+ cell population was purified using anti-CD133 
mAb–coupled magnetic beads (Miltenyi Biotec), according 
to the manufacturer’s instructions. Briefly, to each fraction 
of 108 cells was added 100 µL of Fc-receptor. After that, the 
cells were labeled with 100 µL of CD133 microbeads (final 
volume: 500 µL/108 total cells). The cells were incubated 
for 30 minutes at 4–8°C; after the incubation, the cells were 
washed and resuspended in 500 µL of buffer for every 
108 cells.
The cells, magnetically labeled with antibodies anti-
CD133 microbeads, were separated on a column placed 
in a magnetic field. In this process, the magnetic-labeled 
CD133+ cells were retained in the column, whereas the International Journal of Nanomedicine 2010:5 207
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Figure 2 FMR calibration curve of the sPIONs concentration related with the area under the resonance absorption curve at g = 2.1. In the inset there are presented the 
typical FMR spectra at different concentrations of magnetite contained in the ferrofluid.
Abbreviations: FMR, ferromagnetic resonance; sPIONs, superparamagnetic iron oxide nanoparticles.
unlabeled CD133- cells passed through. After the removal 
of the column from the magnetic field, the magnetically 
retained CD133+ cells could be eluted as the positively 
selected fraction.
Quantification protocol for the magnetic labeling
The quantification methodology followed the same general 
steps presented above and are described below for the in 
vitro case.
Visualization of the sPIONs in the cD133+ cells
After separation, the CD133+ cell population was fixed using 
0.5% glutaraldehyde in 0.2 M cacodylate buffer for two hours 
at 4°C following the routine treatment. The material was then 
transferred to pure Epon resin and incubated at 60°C for 
72 hours, until it was completely polymerized. The ultrathin 
sections, obtained with the aid of an ultramicrotome, were 
placed on copper grids and stained with uranyl acetate and 
lead citrate. The grids were studied and photographed with a 
transmission electron microscope (PHILIPS CM100; Philips, 
Amsterdam, The Netherlands).
calibration curve
The calibration curve shown in Figure 2 was built using 
several FMR absorption spectra measured at room tem-
perature (inset of Figure 2) and containing samples with 
different concentrations with the main goal of determin-
ing the average number of SPIONs per cell. Samples with 
the following concentrations of the cellular label were 
prepared in colloidal suspension: 0.040 ± 0.002; 0.68 ± 
0.04; 1.25 ± 0.30; 1.90 ± 0.04; 2.76 ± 0.03; and 3.58 ± 
0.02 mM. The uncertainties in the FMR spectral intensity 
(area under the g = 2.1 absorption curve) varied in the range 
of a few arbitrary units and hence could not be represented 
in the calibration curves. The volumes of all samples used 
to obtain the FMR spectra were 2 µL. Similarly, as done in 
the in vivo procedure, each measured point was the average 
value of three scans.
FMR measurements of the labeled cells
After labeling, the CD133+ cells were collected in a volume 
of 2 µL for the acquisition of their FMR absorption spectra. 
The indirect interpolation was performed using a sample of International Journal of Nanomedicine 2010:5 208
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the ferrofluid of volume 2 µL containing a known concentra-
tion (1.4 mM).
Results and discussion
case I: in vivo study
Visualization of the sPIONs in the studied tissue
The results of light microscopy clearly showed the conserva-
tion of the morphology of the studied organ in the presence 
of SPIONs. After 15 minutes of iron nanoparticles admin-
istration, Prussian blue-stained structures started to appear 
within the sinusoid capillaries or between hepatocytes rows. 
Thereafter, the intensity of Prussian blue-staining increased, 
indicating a greater number of iron nanoparticle inside mac-
rophages (Figure 3B). Figure 3A shows the micrograph of 
the liver control sample.
FMR identification of SPIONs
The iron entities in the liver and blood were investigated 
at temperatures of 4, 100, and 298 K, firstly focusing on 
the assignment of the resonances due to iron in the FMR 
spectra. Each one of the assignments of the FMR lines 
from liver and blood samples was previously identified by 
Gamarra and colleagues.25 It has been shown that the reso-
nance at g = 2.1 is the total contribution of the administered 
ferrofluid26–28 internalized in the cells of the phagocytic 
mononuclear system such as those of the Kupffer liver 
cells28 and the Fe+3 ions contained in ferritine.29 Therefore, 
the iron resonances in contributions of the FMR spectra 
from the control samples were subtracted from spectra 
of the liver and blood samples and thus only the SPIONs 
contributions were obtained.
The FMR analysis at the three temperatures showed that 
the maximum intensity of the broad line at g = 2.1 due to the 
SPIONs present in the liver and blood samples was obtained 
at 298 K, and therefore this temperature was chosen for the 
present study.
Analysis of the quantification result by FMR
The SPIONs concentrations were determined from the areas 
under the FMR absorption spectra by interpolation in the 
calibration curve shown in Figure 1. The calculation was 
performed with the FMR data from samples obtained after 
the time intervals discussed in the protocol and also from 
the control sample (see Figures 4 and 6 in Gamarra and 
colleagues25). The experimental points represent the average 
values obtained from FMR measurements of three samples 
for each condition under investigation.
In a previous study, Gamarra and colleagues observed 
the close-to-complete disappearance of SPIONs in the blood 
(see Figure 5 in Gamarra and colleagues25), starting within 
60 min after the ferrofluid administration. In that work, a 
first order exponential decay was used for data adjustment. 
Therefore, nanoparticles concentration C(t) in the blood at 
a time t is given by C t C t
B
B ( ) exp( / ) = - 0 τ , where C
B
0  is the 
nanoparticles concentration at t = 0 and τB is the character-
istic time constant of the nanoparticles elimination from the 
blood, equivalent to the time required to eliminate 63% of the 
administered nanoparticles concentration. The half life time 
of the nanoparticles elimination from the blood circulation 
is given by t1/2=τB.In 2.
In order to corroborate the FMR results for the study of 
the ferrofluid elimination in the blood, the XRF technique 
A B
Figure 3 A) Micrograph of liver colored by the Prussian blue from tissues of control animals. B) Micrograph of liver after the sPIONs administration, making evident the 
presence of the nanoparticles in the tissue; bar = 40 µm.
Abbreviation: sPIONs, superparamagnetic iron oxide nanoparticles.International Journal of Nanomedicine 2010:5 209
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was applied to determine the iron concentration in the blood 
using the calibration curve (Figure 1) of the characteristic 
iron lines for different periods of time. The values obtained 
from the curve fitting using both techniques (FMR and XRF) 
are shown in Table 1.
The study of the biodistribution kinetics of the ferrofluid 
in the liver using the FMR and XRF techniques was carried 
out in a similar manner as the study of the sample from 
the blood. The curves reported by Gamarra and colleagues 
(see Figure 5 in Gamarra and colleagues25), obtained from 
the FMR (continuous line) and XRF (dashed line) suggest 
that the magnetic nanoparticles are transferred from the 
blood stream to the liver compartment. It is known that 
the SPIONs are not only transferred to the liver, but also 
to other various organs of the rat.30 The time dependence 
of the nanoparticles concentration in the liver is given 
by C t C t
L
L ( ) [ exp( / )] = - - 0 1 τ , where C
L
0 is the maximum 
nanoparticle concentration that the liver would be able to 
accumulate and τL is the characteristic time of the nanopar-
ticles accumulation in the liver.
The FMR and XRF data were adjusted and the equa-
tion parameters were calculated and are shown in Table 1. 
Both studies of the SPIONs elimination from the blood and 
accumulation in the liver indicate that the results obtained 
from FMR and those obtained from XRF are consistent.
case II: in vitro study
sPIONs visualization in the labeled cells
The ultra-structural results obtained by TEM analyses clearly 
showed the presence of electron-dense granules, indicated 
by arrow 1, on the surface of CD133+ stem cell (Figures 4B 
and C), therefore revealing the presence of the AC133 
Figure 4 A) TeM of the control stem cells cD133-. B, C) TeM of the cD133+ stem 
cells labeled with sPIONs. D) TeM of the cD133+ cells of not conserved morphol-
ogy. n = nucleus, c = cytoplasm, arrow 1 = electrondense granules on the cell surface, 
arrow 2 = electrondense granules in the cell cytoplasm. scale: A) 1.0 µm; B, C) 
0.25 µm; D) 0.5 µm.
Abbreviations:  sPIONs,  superparamagnetic  iron  oxide  nanoparticles;   
TeM, transmission electron microscopy.
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Figure 5 FMR spectra showing the derivative of the absorption of the sPIONs of 
Fe3O4, labeled cells, not labeled cells, and the 0.5% glutaraldehyde fixator.
Abbreviations: FMR, ferromagnetic resonance; sPIONs, superparamagnetic iron 
oxide nanoparticles.
Table 1 Parameters obtained from the curve adjustments of Figures 5 and 7 of Gamarra and colleagues.25 (FMR and XRF data) for the 
study of the kinetics of elimination from the blood and biodistribution in the liver. each parameter of the curves was determined from 
the average value obtained from the results of the measurements of three samples per experimental point
FMR XRF
elimination kinetics (blood)
C
B
0  (particles/mm3)
(7.3 ± 0.1) × 1012 (7.8 ± 0.2) × 1012
τB (min) (16.8 ± 0.8) (18.2 ± 0.8)
t1/2 (min) (11.6 ± 0.6) (12.6 ± 0.6)
Distribution kinetics (liver)
C
L
0  (particles/mm3)
(32 ± 1) × 1011 (31 ± 1) × 1011
τL (min) (24 ± 2) (19 ± 2)
Abbreviations: FMR, ferromagnetic resonance; XRF, X-ray fluorescence.International Journal of Nanomedicine 2010:5 210
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monoclonal antibodies coupled to the SPIONs nanoparticles. 
This finding excludes the control cell (CD133-) which does 
not exhibit the label on its surface (see Figure 4A). The 
SPIONs were also observed in the cytoplasm of the stem 
cell CD133+ (Figure 4C), as indicated by arrow 2, suggest-
ing their internalization through the process of endocytosis 
(pinocytosis).
The previous standardization of this technique has dem-
onstrated a strong electrondense labeling in the periphery 
of the cellular pellet due to the bad fixation of the material, 
which explains the reason why the morphology of the cell 
CD133+ was not conserved (Figure 4D).
Analysis of the result of FMR quantification  
in the cells
In order to clearly show the expression of the antigenic 
epitopes (CD133) for the cell of interest, we first obtained 
only the FMR spectrum of the magnetic beads (Figure 5), 
ie, the AC133 monoclonal antibody coupled to the magnetic 
microspheres composed by SPION (Miltenyi Biotec). We 
observed the resonance at g = 2.1 attributed to Fe3+ ions which 
interact among themselves, showing a superparamagnetic 
behavior31–33 that characterizes the presence of clusters. This 
signal consists of a strong absorption, whose broad width 
is attributed to a strong exchange interaction between suf-
ficiently close Fe ions.
The FMR spectrum of the nonlabeled (CD133-) control 
cells did not present any trace of resonance (Figure 5). 
Thereafter it was obtained the FMR spectrum of the labeled 
CD133+ cells (0.64 × 105 labeled cells in the volume of 2 µL) 
showing a resonance line at g = 2.1 (Figure 5) thus indicating 
the presence of the SPIONs attached to the cells, which were 
embedded in the 0.5% glutaraldehyde fixator.
To make sure that the nanoparticles were not present in 
the fixator, this was removed from the labeled cells by cen-
trifugation (1200 rpm for 10 min) and careful aspiration of 
the supernatant layer. The FMR measurement of the extracted 
fixator was performed and no signal for the glutaraldehyde 
was observed, thus indicating the absence of the SPION 
label in the fixator. This result was confirmed by TEM, being 
observed that the antibodies coupled to the nanoparticles are 
attached to the CD133+ cells (Figures 4B, 4C).
To determine the average number of iron particles 
per cell, it was first determined the number of particles of 
iron contained in the total number of labeled cells CD133+ 
(0.64 × 105) in a volume of 2 µL. The quantification of the 
iron particles in the total of labeled cells was determined 
from the area under the absorption curves of the FMR spectra 
(Figure 7) and subsequent interpolating in the calibration 
curve shown in Figure 2, yielding the value of 1.09 × 10-8 
mole of iron (6.08 × 105 pg) or 4.49 × 1011 Fe3O4 nanopar-
ticles. Consequently, starting from an indirect calculation 
(taking into account the number of cells contained in 2 µL 
of sample) it was estimated a number of 1.7 × 10-13 mol of 
iron (9.5 pg) or 7.01 × 106 iron nanoparticles per cell.
Conclusions
Superparamagnetic iron oxide nanoparticles have been 
experiencing a steady increase of their use in biomedical 
applications, in which cases a detailed characterization of 
their physicochemical properties, including structural and 
magnetic properties, is highly desirable. The results pre-
sented in this paper are thus part of such an effort. Here we 
described the methodology for the quantification of SPIONs 
both in vitro (labeling of stem cells) and in vivo (kinetics of 
biodistribution in the blood and liver of rats).
One of the fundamental steps in starting the quantitative 
analysis in both studies is the procedure of qualitatively 
visualizing the studied samples in order to determine the 
SPIONs location as well as the conservation of the cells 
morphology, which will validate the posterior quantifica-
tion analysis.
Several biological samples contain paramagnetic sub-
stances that appear in the FMR spectra, and which do not 
correspond to the SPIONs. Therefore, it is necessary to 
identify the resonance lines exclusively due to the SPIONs. 
In order to assure the correct assignment, it is important to 
proceed with the subtraction of the resonance spectrum of 
the sample containing the SPIONs from the spectrum of the 
control sample.
After that, the SPIONs concentration is determined 
from the area under the doubly-integrated FMR spectra, 
whose values are interpolated in an adequate calibration 
curves. The SPIONs quantification process by FMR for 
both in vivo and in vitro studies was shown to be a reliable 
method, enabling us to estimate either the SPIONs content 
per volume or per cell. These values will be useful for the 
determination of the administered concentrations of the 
label and to improve the detection ability of other techniques 
such as the MRI.
Acknowledgments
This work was financed by Instituto Israelita de Ensino e 
Pesquisa Albert Einstein (IIEPAE), and CNPq. AJCF also 
thanks the Brazilian agency FAPESP. The authors report no 
conflicts of interest in this work.International Journal of Nanomedicine 2010:5
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
211
FMR for the quantification of SPIONs in biological materials Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
References
  1.  McNeil SE. Nanotechnology for the biologist. J Leukoc Biol. 
2005;78:585–594.
  2.  Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B. 
Superparamagnetic nanoparticles for biomedical applications: Pos-
sibilities and limitations of a new drug delivery system. J Magn Magn 
Mater. 2005;293:483–496.
  3.  Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of 
magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 2003;36:
R167–R181.
  4.  Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an 
emerging discipline evolving from studies of ultrafine particles. Environ 
Health Perspec. 2005;113:823–839.
  5.  Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling 
of mammalian stem cells by combining superparamagnetic iron oxides 
and transfection agents. Radiology. 2003;228:480–487.
  6.  Zhang Z, van de Bos EJ, Wielopolski PA, Jong-Popijus M, Duncker DJ, 
Krestin GP. High-resolution magnetic resonance imaging of iron-
labeled myoblasts using a standard 1.5-T clinical scanner. MAGMA. 
2004;17:201–209.
  7.  Lacava LM, Lacava ZGM, Da Silva MF, et al. Magnetic resonance of 
a dextran-coated magnetic fluid intravenously administered in mice. 
Biophys J. 2001;80:2483–2486.
  8.  Laçava LM, Laçava ZGM, Azevedo RB, et al. Use of magnetic 
resonance to study biodistribution of dextran-coated magnetic fluid 
intravenously administered in mice. J Magn Magn Mater. 2002;252: 
367–369.
  9.  Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V . 
Biodistribution, clearance, and biocompatibility of iron oxide magnetic 
nanoparticles in rats. Mol Pharm. 2008;5:316–327.
10.  Bulte JW, Brooks RA, Moskowitz BM, Bryant LHJ, Frank JA. Relax-
ometry and magnetometry of the MR contrast agent MION-46L. Magn 
Reson Med. 1999;42:379–384.
11.  Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow 
endosomal magnetic labeling and in vivo tracking of stem cells. Nat 
Biotechnol. 2002;19:1141–1147.
12.  Jendelová P, Herynek V , De Croos J, et al. Imaging the fate of implanted 
bone marrow stromal cells labeled with superparamagnetic nanopar-
ticles. Magn Res Med. 2003;50:767–776.
13.  Ali SA, Gene TY, Heather K, et al. Efficient magnetic cell labeling with 
protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 
2004;104:1217–1223.
14.  He G, Zhang H, Wei H, et al. In vivo imaging of bone marrow mes-
enchymal stem cells transplanted into myocardium using magnetic 
resonance imaging: A novel method to trace the transplanted cells. Int 
J Cardiol. 2007;114:4–10.
15.  Wilhelm C, Gazeau F, Bacri JC. Magnetophoresis and ferromagnetic reso-
nance of magnetically labeled cells. Eur Biophys. 2002;31:118–125.
16.  Hinds KA, Hill JM, Shapiro EM, et al. Highly efficient endosomal 
labeling of progenitor and stem cells with large magnetic particles 
allows magnetic resonance imaging of single cells. Blood. 2003; 
102:867–872.
17.  Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance 
imaging of injected mesenchymal stem cells. Circulation. 2003; 
26:1009–1014.
18.  Rivière Ch, Boudghène FP, Gazeau F, et al. Iron oxide nanoparticle-
labeled rat smooth muscle cells: cardiac MR imaging for cell graft 
monitoring and quantitation. Radiology. 2005;235:959–967.
19.  Weissleder R, Bogdanov A, Neuweltb EA, Papisov M. Long-circulating 
iron oxides for MR imaging. Adv Drug Deliv Rev. 1995;16:321–334.
20.  Jendelová P, Herynek V , Urdzíková L, et al. Magnetic resonance track-
ing of transplanted bone marrow and embryonic stem cells labeled by 
iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res. 
2004;76:232–243.
21.  Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical 
and metabolic properties of cells labeled with superparamagnetic iron 
oxide nanoparticles and transfection agent for cellular MR imaging. 
Radiology. 2003;229:838–846.
22.  Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F. 
Cell internalization of anionic maghemite nanoparticles: quantita-
tive effect on magnetic resonance imaging. Magn Reson Med. 2003; 
49:646–654.
23.  Laniado M, Chachuat A. Verträglichkeitsprofil von ENDOREM. 
Radiologe. 1995;35(Suppl. e):S266–S270.
24.  Lehner M, Holter W. Endotoxin-free purification of monocytes for 
dendritic cell generation via discontinuous density gradient centrifuga-
tion based on diluted Ficoll-Paque Plus®. Int Arch Allergy Immunol. 
2002;128:73–76.
25.  Gamarra LF, Pontuschka WM, Amaro JrE, et al. Kinetics of elimination 
and distribution in blood and liver of biocompatible ferrofluids based 
on Fe3O4 nanoparticles: An EPR and XRF study. Mater Sci Eng C. 
2008;28:519–525.
26.  Lacava LM, Lacava ZGM, da Silva MF, et al. Magnetic resonance of 
a dextran-coated magnetic fluid intravenously administered in mice. 
Biophys J. 2001;80:2483–2486.
27.  Sharma VK, Waldner F. Superparamagnetic and ferrimagnetic 
resonance of ultrafine Fe3O4 particles in ferrofluids. J Appl Phys. 
1997;48:4298–4302.
28.  Lacava LM, Garcia VAP, Kückelhaus S, et al. Magnetic resonance 
and light microscopy investigation of a dextran coated magnetic fluid. 
J Appl Phys. 2003;93:7563–7565.
29.  Slawska-Waniewska A, Mosiniewicz-Szablewska E, Nedelko N, 
Galazka-Friedman J, Friedman A. Magnetic studies of iron-entities in 
human tissues. J Magn Magn Mater. 2004;272:2417–2419.
30.  Weissleder R, Bogdanov A, Neuweltb EA, Papisov M. Long-
circulating iron oxides for MR imaging. Adv Drug Deliv Rev. 1995; 
16:321–334.
31.  Gamarra LF, Brito GES, Pontuschka WM, Amaro JrE, Parma AHC, 
Goya GF. Biocompatible superparamagnetic iron oxide nanoparticles 
used for contrast agents: a structural and magnetic study. J Magn Magn 
Mater. 2005;289:439–441.
32.  Hseih CT, Huang WL, Lue JT. The change from paramagnetic resonance 
to ferromagnetic resonance for iron nanoparticles made by the sol-gel 
method. J Phys Chem Sol. 2002;63:733–741.
33.  Sharma VK, Waldner F. Superparamagnetic and ferrimagnetic 
resonance of ultrafine Fe3O4 particles in ferrofluids. J Appl Phys. 
1997;48:4298–4302.